Skip to search formSkip to main contentSkip to account menu

Reviparin sodium

Known as: reviparin-sodium 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2004
Review
2004
Reviparin sodium (clivarine) is a second generation LMWH, developed with the aim of maximising the antithrombotic action while… 
Highly Cited
2002
Highly Cited
2002
BACKGROUND Oral anticoagulants and low-molecular-weight heparin are both recommended for venous thromboembolism prophylaxis after… 
2002
2002
Periprocedural and postprocedural anticoagulation during arterial reconstructive surgery (ARS) with intravenous heparin is… 
Highly Cited
2001
Highly Cited
2001
PURPOSE Deep venous thrombosis (DVT) is a common, important complication of major orthopaedic surgery, particularly knee… 
2001
2001
Previous studies in rats show that unfractionated heparin and the low molecular weight heparin logiparin have a dose-dependent… 
Review
2001
Review
2001
UNLABELLED Reviparin (reviparin sodium) is a low molecular weight heparin (LMWH) that catalyses the inactivation of factors Xa… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND Low-molecular-weight heparin is known to be safe and effective for the initial treatment of patients with proximal… 
1997
1997
A prospective, randomised, controlled clinical trial was carried out in order to elucidate the incidence of venous… 
1997
1997
Summary. A prospective, randomised, controlled clinical trial was carried out in order to elucidate the incidence of venous…